Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Feng Lin

Showing results (101-110 of 127) with videos related to

Pageof 13
Sort By:
Molecular Therapy. Nucleic Acids|June 18, 2021
Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinomaShu-Hsuan Liu, Kai-Wen Hsu, Yo-Liang Lai, et al.
Blood Purification|December 5, 2008
A modified sequential organ failure assessment score to predict hospital mortality of postoperative acute renal failure patients requiring renal replacement therapyYu-Feng Lin, Wen-Je Ko, Vin-Cent Wu, et al.
Intensive Care Medicine|August 19, 2007
Risk factors of early redialysis after weaning from postoperative acute renal replacement therapyVin-Cent Wu, Wen-Je Ko, Hong-Wei Chang, et al.
Nanotechnology|August 12, 2011
Preparation and properties of a carbon nanotube-based nanocomposite photoanode for dye-sensitized solar cellsChuan-Yu Yen, Yu-Feng Lin, Shu-Hang Liao, et al.
Scientific Reports|September 29, 2016
Losartan reduces ensuing chronic kidney disease and mortality after acute kidney injuryShun-Yang Cheng, Yu-Hsiang Chou, Fang-Ling Liao, et al.
Blood|July 13, 2006
Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs)Barbara Savoldo, John A Goss, Markus M Hammer, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 25, 2010
Benefits of sevelamer on markers of bone turnover in Taiwanese hemodialysis patientsYu-Feng Lin, Yung-Ming Chen, Kuan-Yu Hung, et al.
Cytotherapy|May 1, 2010
Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experienceConrad Russell Cruz, Patrick J Hanley, Hao Liu, et al.
Biomedical Journal|January 27, 2024
Gut microbiota and clinical response to immune checkpoint inhibitor therapy in patients with advanced cancerJohn Wen-Cheng Chang, Jia-Juan Hsieh, Chih-Yu Tsai, et al.
American Journal of Surgery|April 21, 2009
Sustained low-efficiency dialysis versus continuous veno-venous hemofiltration for postsurgical acute renal failureVin-Cent Wu, Chih-Hsien Wang, Wei-Jie Wang, et al.
Pageof 13

Showing results (101-110 of 127) with videos related to

Sort By:
Pageof 13
Molecular Therapy. Nucleic Acids|June 18, 2021
Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinomaShu-Hsuan Liu, Kai-Wen Hsu, Yo-Liang Lai, et al.
Blood Purification|December 5, 2008
A modified sequential organ failure assessment score to predict hospital mortality of postoperative acute renal failure patients requiring renal replacement therapyYu-Feng Lin, Wen-Je Ko, Vin-Cent Wu, et al.
Intensive Care Medicine|August 19, 2007
Risk factors of early redialysis after weaning from postoperative acute renal replacement therapyVin-Cent Wu, Wen-Je Ko, Hong-Wei Chang, et al.
Nanotechnology|August 12, 2011
Preparation and properties of a carbon nanotube-based nanocomposite photoanode for dye-sensitized solar cellsChuan-Yu Yen, Yu-Feng Lin, Shu-Hang Liao, et al.
Scientific Reports|September 29, 2016
Losartan reduces ensuing chronic kidney disease and mortality after acute kidney injuryShun-Yang Cheng, Yu-Hsiang Chou, Fang-Ling Liao, et al.
Blood|July 13, 2006
Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs)Barbara Savoldo, John A Goss, Markus M Hammer, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 25, 2010
Benefits of sevelamer on markers of bone turnover in Taiwanese hemodialysis patientsYu-Feng Lin, Yung-Ming Chen, Kuan-Yu Hung, et al.
Cytotherapy|May 1, 2010
Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experienceConrad Russell Cruz, Patrick J Hanley, Hao Liu, et al.
Biomedical Journal|January 27, 2024
Gut microbiota and clinical response to immune checkpoint inhibitor therapy in patients with advanced cancerJohn Wen-Cheng Chang, Jia-Juan Hsieh, Chih-Yu Tsai, et al.
American Journal of Surgery|April 21, 2009
Sustained low-efficiency dialysis versus continuous veno-venous hemofiltration for postsurgical acute renal failureVin-Cent Wu, Chih-Hsien Wang, Wei-Jie Wang, et al.
Pageof 13